SMARCB1 and schwannoma: Such hypomorphic pathogenic SMARCB1 variants may explain why patients with these variants and SMARCB1-related SWN exhibit benign schwannomas during adulthood but usually do not develop the highly malignant pediatric AT/RT characterized by the complete loss-of-function of SMARCB1 (Sect.